Lysophosphatidylinositols Are Upregulated After Human β-Cell Loss and Potentiate Insulin Release.

MLA

Jiménez-Sánchez, Cecilia, et al. “Lysophosphatidylinositols Are Upregulated After Human β-Cell Loss and Potentiate Insulin Release.” Diabetes, vol. 73, no. 1, Jan. 2024, pp. 93–107. EBSCOhost, https://doi.org/10.2337/db23-0205.

APA

Jiménez-Sánchez, C., Sinturel, F., Mezza, T., Loizides-Mangold, U., Montoya, J. P., Li, L., Di Giuseppe, G., Quero, G., Guessous, I., Jornayvaz, F., Schrauwen, P., Stenvers, D. J., Alfieri, S., Giaccari, A., Berishvili, E., Compagnon, P., Bosco, D., Riezman, H., Dibner, C., & Maechler, P. (2024). Lysophosphatidylinositols Are Upregulated After Human β-Cell Loss and Potentiate Insulin Release. Diabetes, 73(1), 93–107. https://doi.org/10.2337/db23-0205

Chicago

Jiménez-Sánchez, Cecilia, Flore Sinturel, Teresa Mezza, Ursula Loizides-Mangold, Jonathan Paz Montoya, Lingzi Li, Gianfranco Di Giuseppe, et al. 2024. “Lysophosphatidylinositols Are Upregulated After Human β-Cell Loss and Potentiate Insulin Release.” Diabetes 73 (1): 93–107. doi:10.2337/db23-0205.